Evidence map›Paper›PMID 27143514›Full record

ArticleScientific reports2016

Identification and manipulation of the pleuromutilin gene cluster from Clitopilus passeckerianus for increased rapid antibiotic production.

Andy M Bailey, Fabrizio Alberti, Sreedhar Kilaru, Catherine M Collins, Kate de Mattos-Shipley, Amanda J Hartley, Patrick Hayes, Alison Griffin, Colin M Lazarus, Russell J Cox and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 114 citations in OpenAlex.

  1. Review
  2. RSC advances · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Seven new species of theMycoKeys · 2026
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. IMA fungus · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Andy M BaileySchool of Biological Sciences, Life Sciences Building, University of Bristol, 24 Tyndall Avenue, Bristol, BS8 1TQ, UK.
Fabrizio AlbertiSchool of Biological Sciences, Life Sciences Building, University of Bristol, 24 Tyndall Avenue, Bristol, BS8 1TQ, UK.
Sreedhar KilaruSchool of Biological Sciences, Life Sciences Building, University of Bristol, 24 Tyndall Avenue, Bristol, BS8 1TQ, UK.
Catherine M CollinsSchool of Biological Sciences, Life Sciences Building, University of Bristol, 24 Tyndall Avenue, Bristol, BS8 1TQ, UK.
Kate de Mattos-ShipleySchool of Biological Sciences, Life Sciences Building, University of Bristol, 24 Tyndall Avenue, Bristol, BS8 1TQ, UK.
Amanda J HartleySchool of Biological Sciences, Life Sciences Building, University of Bristol, 24 Tyndall Avenue, Bristol, BS8 1TQ, UK.
Patrick HayesSchool of Biological Sciences, Life Sciences Building, University of Bristol, 24 Tyndall Avenue, Bristol, BS8 1TQ, UK.
Alison GriffinGSK, Southdownview Way, Worthing, West Sussex, BN14 8QH, UK.
Colin M LazarusSchool of Biological Sciences, Life Sciences Building, University of Bristol, 24 Tyndall Avenue, Bristol, BS8 1TQ, UK.
Russell J CoxSchool of Chemistry, University of Bristol, Cantock's Close Bristol, BS8 1TS, UK.
Christine L WillisSchool of Chemistry, University of Bristol, Cantock's Close Bristol, BS8 1TS, UK.
Karen O'DwyerGSK, 1250 S. Collegeville Road, Collegeville, Pennsylvania, 19426-0989, United States.
David W SpenceSchool of Chemistry, University of Bristol, Cantock's Close Bristol, BS8 1TS, UK.
Gary D FosterSchool of Biological Sciences, Life Sciences Building, University of Bristol, 24 Tyndall Avenue, Bristol, BS8 1TQ, UK.
University of Bristol · GBWorthing Hospital · GB

Funding

Biotechnology and Biological Sciences Research Council D19266
6 · The paper itself

Abstract

Semi-synthetic derivatives of the tricyclic diterpene antibiotic pleuromutilin from the basidiomycete Clitopilus passeckerianus are important in combatting bacterial infections in human and veterinary medicine. These compounds belong to the only new class of antibiotics for human applications, with novel mode of action and lack of cross-resistance, representing a class with great potential. Basidiomycete fungi, being dikaryotic, are not generally amenable to strain improvement. We report identification of the seven-gene pleuromutilin gene cluster and verify that using various targeted approaches aimed at increasing antibiotic production in C. passeckerianus, no improvement in yield was achieved. The seven-gene pleuromutilin cluster was reconstructed within Aspergillus oryzae giving production of pleuromutilin in an ascomycete, with a significant increase (2106%) in production. This is the first gene cluster from a basidiomycete to be successfully expressed in an ascomycete, and paves the way for the exploitation of a metabolically rich but traditionally overlooked group of fungi.

Indexed as

Metabolic EngineeringMultigene FamilyAgaricalesAnti-Bacterial AgentsAspergillus oryzaeBiosynthetic PathwaysCloning, MolecularDiterpenesPleuromutilinsPolycyclic CompoundsRecombinant ProteinsAnti-Bacterial AgentsDiterpenesPleuromutilinsPolycyclic CompoundsRecombinant Proteins

Identifiers

PMID27143514
PMCPMC4855138
OpenAlexW2346047962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.